Michael Peel has been science editor of the Financial Times since October 2023. He covers all elements of science, from the sub-microscopic to the cosmic.
Michael is a chemistry graduate and has been an FT journalist for more than 25 years, including postings in Lagos, Abu Dhabi, Bangkok and Brussels. He has been seconded in Tokyo as executive editor of Nikkei Asia. He is the author of The Fabulists: How Myth-makers Rule in an Age of Crisis (Paperback 2021) and A Swamp Full of Dollars: Pipelines and Paramilitaries at Nigeria’s Oil Frontier (2009), which was shortlisted for the Guardian First Book Award.
Add this topic to your myFT Digest for news straight to your inbox
Discovery boosts efforts to develop ‘biomarkers’ for debilitating condition and enable treatments
Sir John Bell, who helped ministers during the Covid crisis, says a business leader could run the UK research awards body
Research highlights risks posed by pan-continental reforestation project
New molecule proves effective in animals against several drug-resistant bacteria
Large study further boosts fast-evolving efforts to predict and prevent neurogenerative diseases
STEP is successor to 40-year-old record-breaking EU project in Oxfordshire
Debate over funding of ‘pure science’ ventures heats up with ambitious proposal for 91km supercollider
Ocean temperature research sparks debate about baseline measure for climate change
Competitors shrug at the billionaire’s claims but acknowledge that the attention has helped to propel the field closer to reality
Huge reduction in bouts of angioedema increases prospect that technique can combat a range of diseases
Cases connected to growth hormone extracted from cadavers show disease’s parallels with CJD brain disorder
Authorities urged to improve access to jabs and address suspicion of them
Government targets tens of thousands of businesses to tap €95.5bn pot
Research boosts efforts to diagnose and devise treatments for debilitating condition
Google’s AI unit shows the technology’s growing proficiency with AlphaGeometry getting close to matching top students
‘Molecular factories’ boost field of synthetic biology, raising hopes of developing drugs and other products
Study harnesses millennia-old human DNA to plot ‘genetic divide’ on origin and spread of health risks
Potential remedy targets leading antibiotic-resistant pathogen that causes life-threatening infections in patients
January deadline will be first test of Britain’s prospects after three years away from the scheme
Research into ‘colonisation resistance’ boosts efforts to harness microbes to improve general health
Organoid helps system recognise speech and solve maths problems showing potential of neuromorphic technology
Abu Dhabi-backed G42 says it ‘cannot work with both sides’ and retain access to American-made AI chips
Use of technology to solve scientific problems still falls short of commercialisation
Deal with Absci is the latest between big pharma and tech companies to build new disease treatments
‘Treasure trove’ will be used to develop drugs and treatments for wide range of diseases and is culmination of 20 years of work
International Edition